In this podcast, we feature an article that looks at the policy debate to repatriate and increase domestic drug manufacturing in the US in light of the COVID-19 pandemic and pharmaceutical supply-chain vulnerabilities. For a text version of this article visit dcatvci.org.

Key topics: (see Chapter Markers)

• A plan for addressing supply-chain vulnerabilities in the US
• Legislative proposals in the US